FSP1 inhibitor (ifsp1) can reverse the ferroptosis resistance caused by FSP1, increasing the sensitivity of lung cancer cells to ferroptosis and promoting ferroptosis of lung cancer cells (46). Here, AIFM2 is linked to lung carcinoma.